Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Alembic Pharmaceuticals Ltd.

NSE: APLLTD | BSE: 533573 | ISIN: INE901L01018 | Industry: Pharmaceuticals
| Mid-range Performer

947.1500 -4.80 (-0.50%)

NSE Sep 11, 2025 15:31 PM

27.36% Fall from 52W High

Volume: 105.9K

Alembic Pharmaceuticals Ltd.

19 Aug 2025

947.15

-0.50%

Company Update

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets, 10mg.

More from Alembic Pharmaceuticals Ltd.

Recommended

Market closes higher, Tega Industries to buy Molycop with Apollo Funds in a $1.5 bn deal

Trendlyne Marketwatch | 11 Sep 2025, 04:07PM

India’s IPO story in 2025: Investors go selective, backing quality over hype

The Baseline | 11 Sep 2025, 03:50PM

Earnings Call Transcript - Q1FY21 for Alembic Pharmaceuticals